Randomized Controlled Crossover Trials of the Pharmacokinetics of PRC-063, a Novel Multilayer Extended-Release Formulation of Methylphenidate, in Healthy Adults

PURPOSE/BACKGROUND: PRC-063 is a once-daily, extended-release oral formulation of methylphenidate hydrochloride developed to provide early and prolonged symptom improvement in patients with attention-deficit/hyperactivity disorder. METHODS/PROCEDURES: We conducted 3 randomized, open-label crossover...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Clin Psychopharmacol
Autors principals: Katzman, Martin A., Mattingly, Greg, Klassen, Larry J., Cataldo, Marc J., Donnelly, Graeme A. E.
Format: Artigo
Idioma:Inglês
Publicat: Lippincott Williams & Wilkins 2020
Matèries:
Original Contributions
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7643797/
https://ncbi.nlm.nih.gov/pubmed/33009228
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/JCP.0000000000001277
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars